Trial intelligence / Profile preview

Tauro ursodeoxycholic acid for prevention of gallstone relapse after gallbladder-preserving lithotomy

ChiCTR-TRC-11001932Phase 4Completed

Sponsor
Western Theater Air Force Hospital
Start
Jul 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of tauroursodeoxycholic acid in Cholecystolithiasis (4 arms), sponsored by Western Theater Air Force Hospital. Primary endpoint: Relapse of cholecystolithiasis. Started Jul 2010; status: completed.

02

Drugs

tauroursodeoxycholic acid
03

Conditions

Cholecystolithiasis

Beyond the preview

Go deeper on ChiCTR-TRC-11001932.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-11001932.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call